As of Wednesday close, Medtronic plc’s (NYSE:MDT) stock was up $1.09, moving up 1.40 percent to $79.02. The average number of shares traded per day over the past five days has been 10,658,320 shares. 3 times new highs have been achieved over the past 5 days, with a -$2.76 fall in that time frame. In the last twenty days, the average volume was 7,926,720, while in the previous 50 days, it was 6,697,412.
Since last month, MDT stock retreated -6.49%. Shares of the company fell to $76.60 on 11/22/22, the lowest level in the past month. A 52-week high of $115.61 was reached on 04/21/22 after having rallying from a 52-week low of $76.60. Since the beginning of this year, MDT’s stock price has dropped by -23.62% or -$24.43, and marked a new high 12 times. However, the stock has declined by -31.65% since its 52-week high.
China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal
Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.
Simply click here and the name & trading symbol are yours.
MDT stock investors should be aware that Medtronic plc (MDT) stock had its last reported insider trading activity 42 days ago on Oct 14. TEN HOEDT ROB, the EVP and Pres. Global Regions of the company, disposed of 2,404 shares for $81.54 on Oct 14. It resulted in a $196,015 divestment by the insider. PARKHILL KAREN L sold 682 shares at an average price of $110.00 on Mar 18. The insider now owns 34,946 shares following the transaction. On Mar 11, SVP, Chief HR Officer Surface Carol A sold 6,000 shares at $105.30 apiece. The transaction was valued at $631,800.
Right now, Medtronic plc (MDT) has a P/E ratio of about 20.43. The stock’s beta is 0.77. Besides these, the trailing price-to-sales (P/S) ratio of 3.32, the price-to-book (PB) ratio of 1.99, and the price-to-cash flow ratio of 45.26 may also be considered.
The latest dividend of $0.68 per share was paid out, remained unchanged from last year’s $0.68. On Wednesday May 25 2022, a $0.05 dividend increase was announced.
In the three months ended October 30, Medtronic plc’s quick ratio stood at 1.20, while its current ratio was 1.60, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending October 30 was 0.33, and the total debt-to-equity ratio was 0.44. On the profitability front, the trailing twelve-month gross margin is 67.90% percent. In the year ended October 30, operating margins totaled 19.20%. Based on annual data, MDT earned $21.54 billion in gross profit and brought in $31.69 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 6.90%. Return on equity (ROE) for the past 12 months was 9.90%.
In Medtronic plc’s quarter-end financial report for October 30, it reported total debt of $17.48 billion against cash and short-term investments of $6.73 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. MDT’s revenue fell -8.36% to $8.09 billion during the quarter, while net income inched up to $7.37 billion. While analysts expected Medtronic plc to report $1.28 quarterly earnings, the actual figure was $1.3 per share, beating the consensus estimate by 1.60%. During the quarter, the company generated $1.79 billion in EBITDA. The liabilities of Medtronic plc were 37.07 billion at the end of its most recent quarter ended October 30, and its total debt was $26.62 billion. The value of shareholders’ equity is $1.33 billion.
This quick technical analysis looks at Medtronic plc’s (MDT) price momentum. With a historical volatility rate of 36.82%, the RSI 9-day stood at 39.31% on 23 November.
With respect to its five-day moving average, the current Medtronic plc price is down by -3.37% percent or -$2.76. At present, MDT shares trade -7.44% below its 20-day simple moving average and -12.68% percent below its 100-day simple moving average. However, the stock is currently trading approximately -12.80% below its SMA50 and -24.17% below its SMA200.
Stochastic coefficient K was 24.34% and Stochastic coefficient D was 22.69%, while ATR was 2.51. Given the Stochastic reading of 26.19% for the 14-day period, the RSI (14) reading has been calculated as 40.99%. As of today, the MACD Oscillator reading stands at -1.60, while the 14-day reading stands at -1.94.
Medtronic plc downgraded its rating on Medtronic plc (NYSE: MDT) to a Perform in a note to investors on November 23, 2022. The analysts firm previously had an Outperform rating on the stock.Medtronic plc (MDT) has been rated Overweight by analysts. According to 1 brokerage firm, MDT is a sell, and 16 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate Medtronic plc stock as buy, with 10 recommending it as overweight.
With a median target price of $88.00, the current consensus forecast for the stock is $79.00 – $127.00. Based on these forecasts, analysts predict Medtronic plc (MDT) will achieve an average price target of $90.05.